Neurocrine Bio. (NBIX) PT Raised to $131 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $153.88 -0.12%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $131.00 (from $125.00) while maintaining a Buy rating.
You May Also Be Interested In
- Coinbase (COIN) PT Raised to $212 at Cantor Fitzgerald
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $105 at Jefferies
- Freedom Broker Downgrades STRATTEC Security (STRT) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
